The HLA-B∗39 allele increases type 1 diabetes risk conferred by HLA-DRB1∗04:04-DQB1∗03:02 and HLA-DRB1∗08-DQB1∗04 class II haplotypes
Autor: | Riitta Veijola, Jorma Ilonen, Antti-Pekka Laine, Minna Kiviniemi, Mikael Knip, Finnish Paediatric Diabetes Register, Taina Härkönen, Olli Simell, Mari‐Liis Mikk |
---|---|
Rok vydání: | 2014 |
Předmět: |
Genetics
Immunology Haplotype HLA-B39 Antigen Sequence Analysis DNA General Medicine Human leukocyte antigen Biology ta3111 HLA-B Minor allele frequency Diabetes Mellitus Type 1 Haplotypes Genotype Humans Immunology and Allergy Genetic Predisposition to Disease Registries Allele HLA-DRB1 Allele frequency Alleles Finland HLA-DRB1 Chains |
Zdroj: | Human Immunology. 75(1):65-70 |
ISSN: | 0198-8859 |
DOI: | 10.1016/j.humimm.2013.09.008 |
Popis: | To further characterise the effect of the HLA-B ∗ 39 allele on type 1 diabetes risk we assessed its role in different HLA-DR/DQ haplotypes and genotypes using 1764 nuclear families with a diabetic child collected in the framework of the Finnish Paediatric Diabetes Register. HLA assays were based on sequence specific hybridization using lanthanide labelled oligonucleotide probes. Transmissions of major HLA-DR/DQ haplotypes with and without the HLA-B ∗ 39 allele to diabetic index cases were analysed by direct haplotype and allele counting. The HLA-B ∗ 39 allele significantly increased the disease risk conferred by DRB1 ∗ 04:04-DQA1 ∗ 03-DQB1 ∗ 03:02 and (DR8)-DQB1 ∗ 04 haplotypes. The same effect was observed on genotype level as disease association for the HLA-B ∗ 39 allele was observed in multiple genotypes containing DRB1 ∗ 04:04-DQA1 ∗ 03-DQB1 ∗ 03:02 or (DR8)-DQB1 ∗ 04 haplotypes. Finally we considered the two common subtypes of the HLA-B ∗ 39 allele, B ∗ 39:01 and B ∗ 39:06 and observed their unequal distribution when stratified for specific DR-DQ haplotypes. The risk for type 1 diabetes conferred by certain DR/DQ haplotypes is modified by the presence of the HLA-B ∗ 39 and this confirms the independent disease predisposing effect of the HLA-B ∗ 39 allele. The results can be applied in enhancing the sensitivity and specificity of DR/DQ based screening programs for subjects at disease risk. |
Databáze: | OpenAIRE |
Externí odkaz: |